Optum — UnitedHealth Group’s division that controls one of the nation’s largest pharmacy benefit managers — is moving to improve access and pricing for prescription drugs by cutting some ...

Optum notable drugs nearing FDA approval include Anaphylm, Sotyktu, and insulin icodec with decisions expected early 2026.

Health care provider Optum has backed away from its plan to purchase Steward Health Care’s national physicians group, dealing a major setback to Steward’s efforts to bolster its finances after filing ...

U.S. private equity firm TPG is close to acquiring UnitedHealth's Optum UK business, in a deal worth between 1.2 billion ...

The home health bidding wars are heating up as UnitedHealth Group's Optum unit is making a big play for home health and hospice firm Amedisys. Just one month ago, Amedisys agreed to be bought by ...

A move by Optum to change longstanding practices for licensing data to academic institutions has sparked an outcry among researchers, who argue the move will make accessing data so costly and ...

LAS VEGAS—Optum Rx is planning to add up to three biosimilar drugs to its formulary to compete directly with AbbVie's Humira, which accounts for massive pharmacy spend each year. Optum Rx, the ...

Optum is closing a plant in Ohio, laying off 129 employees, according to a May 16 letter from Optum to the Rapid Response Program Administrator in that state. Optum gave the mandated WARN notice, the ...

A contract termination between Optum and Humana, as well as the expiration of enhanced tax credits for people covered by ...

UnitedHealth Group’s Optum health services business Monday made an unsolicited cash offer of more than $3 billion to the board of home health provider Amedisys. The “all-cash offer,” valued at nearly ...